Jefferies Group’s LeonaBio Inc LONA Stock Holding History

Jefferies Group’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,130	Closed	-$553K	–	1643
2022 Q2	$553K	Buy	+18,130	New	+$1.66M	﹤0.01%	956

Other funds holding LONA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Group's LONA Position: Q3 2022 in Review

Jefferies Group sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 20,126 shares — an estimated $614K sold.

Jefferies Group first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $614K in Q2 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

Jefferies Group reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 20,126 LeonaBio Inc shares in Q3 2022, an estimated $614K.
Jefferies Group first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
Jefferies Group's LeonaBio Inc position peaked at $614K in Q2 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.